Trials / Terminated
TerminatedNCT04753957
Pharmacokinetics of Progesterone in Pregnancy-2
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- Thomas Jefferson University · Academic / Other
- Sex
- Female
- Age
- 16 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to evaluate the local pharmacokinetics of progesterone in pregnancy through evaluation of progesterone levels in maternal serum, endometrium, and cordblood in pregnant patients undergoing scheduled cesarean delivery.
Detailed description
The objective of this pilot study is to evaluate the local pharmacokinetics of progesterone in pregnancy through evaluation of progesterone levels in maternal serum, endometrium, and cordblood in pregnant patients undergoing scheduled cesarean delivery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | micronized Progesterone | 200mg micronized progesterone placed vaginally |
Timeline
- Start date
- 2022-01-07
- Primary completion
- 2022-02-01
- Completion
- 2022-02-01
- First posted
- 2021-02-15
- Last updated
- 2022-05-26
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04753957. Inclusion in this directory is not an endorsement.